NAV
$255.29
AUM
$2.6B
Expense Ratio
-
Dividend Yield
0.01%
Beta
0.78
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +23.65% | +14.64% | +27.07% | +57.58% | +19.04% | +8.15% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | CORT | Corcept Therapeutics Inc | 4.97% |
| 2 | BRKR | Bruker Corp | 4.70% |
| 3 | VCYT | Veracyte Inc | 4.47% |
| 4 | NEO | NeoGenomics Inc | 4.10% |
| 5 | ILMN | Illumina Inc | 4.04% |
| 6 | AXSM | Axsome Therapeutics Inc | 3.95% |
| 7 | ALKS | Alkermes PLC | 3.79% |
| 8 | NBIX | Neurocrine Biosciences Inc | 3.68% |
| 9 | ARWR | Arrowhead Pharmaceuticals Inc | 3.59% |
| 10 | KRYS | Krystal Biotech Inc | 3.58% |
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.
Inception Date: 2006-06-19